Home > Blog Tag

Blog Posts by Tag: Molecular

Three Questions You Should Be Asking to Determine if the No Surprises Act Applies to You

How do the billing protections established under the No Surprises Act impact my group?This is what everyone is asking. It’s a very complex question that isn’t answered with a simple yes or no. However, listed below are three questions you should ask to determine if any of your services are impacted by the No Surprise Act legislation.*  Is the...

Read


No Surprises Act: Your Top Questions Answered - Part 2

This blog is part two of a blog series focusing on answering the most common questions regarding the No Surprises Act. View Part One, which focused on questions related to providing a good faith estimate and obtaining patient consent.The No Surprises Act (NSA) — which provides patient protections by addressing surprise billing and banning balance billing — has many people wondering which parts of...

Read


An LIS Built to Support the Future of Diagnostics

The pandemic has taught the lab industry many valuable lessons. As an industry we need to be nimble and prepared to expand our operations rapidly, not only to manage larger volumes of testing but new diagnostic tests, as well.The laboratory information system (LIS) plays a vital role in test menu expansion, from receiving electronic orders or manually accessioning cases to providing an ordering...

Read


No Surprises Act: Your Top Questions Answered - Part 1

The No Surprises Act (NSA), which went into effect on January 1, has many providers scrambling. The No Surprises Act provided protections for patients who unknowingly receive care from an out-of-network provider by addressing surprise billing and banning balance billing. Implementing the requirements of the No Surprises Act will require a new level of coordination between providers, payors, and...

Read


Integrating Informatics for Clinical-Genomic Collaboration and Analysis

I recently had the pleasure of co-authoring an article in Oncology Practice Management. The article, titled “An Integrated Informatics Approach for Clinical-Genomic Knowledge Sharing and Analysis” outlines the design of a real-time registry that aggregates heterogeneous clinical and genomic data (along with other molecular results) in a unified structure to identify, vet, and fulfill...

Read


Preparing for the No Surprises Act: Learn How Your Billing Solution Can Help

Effective January 1, 2022, the No Surprises Act (NSA) established new federal protections against surprise medical bills and balance billing for services received from out-of-network providers. The Act applies to emergency and non-emergency services provided by all healthcare providers and all commercial health plans. The No Surprises Act is not applicable to Medicare and Medicaid programs,...

Read


XIFIN Acquisition Opens Opportunities for Diagnostics Providers, Targets Patient-Centric Care

XIFIN recently announced the acquisition of OmniSYS, a healthcare technology company that serves more than 30,000 pharmacies, including four out of the top five national chains. OmniSYS capabilities include patient engagement, medical claims processing, automated pricing, managing clinical workflow, and supporting new clinical services such as immunizations, medication management, point-of-care...

Read


How Precision Medicine and Data Analytics Impact the Journey of Patients with Cancer

Earlier this year, I had the pleasure of co-authoring an article in Oncology Practice Management with Randy Erickson, RN, MBA, Chief Executive Officer of Utah Cancer Specialists and Linh Mekuria, MPA, clinical informaticist with XIFIN, Inc. The article, titled “The Intersection of Precision Medicine and Data Analysis in the Community Oncology Setting” explores the role of precision medicine and...

Read